Loading…
Elevated phase amplitude coupling as a depression biomarker in epilepsy
•A broad theta-alpha-beta phase (5–25 Hz)-gamma amplitude (80–100 Hz) elevated Phase Amplitude Coupling signal differentiated depressed from non-depressed epilepsy patients.•Phase Amplitude Coupling may be an anatomically specific, putative biomarker candidate of active sustained depressive symptoms...
Saved in:
Published in: | Epilepsy & behavior 2024-03, Vol.152, p.109659-109659, Article 109659 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •A broad theta-alpha-beta phase (5–25 Hz)-gamma amplitude (80–100 Hz) elevated Phase Amplitude Coupling signal differentiated depressed from non-depressed epilepsy patients.•Phase Amplitude Coupling may be an anatomically specific, putative biomarker candidate of active sustained depressive symptoms in patients with epilepsy.•Phase Amplitude Coupling signal differed in brain regions between neocortical epilepsy and mesial temporal epilepsy patients.
Depression is prevalent in epilepsy patients and their intracranial brain activity recordings can be used to determine the types of brain activity that are associated with comorbid depression. We performed case-control comparison of spectral power and phase amplitude coupling (PAC) in 34 invasively monitored drug resistant epilepsy patients’ brain recordings. The values of spectral power and PAC for one-minute segments out of every hour in a patient’s study were correlated with pre-operative assessment of depressive symptoms by Beck Depression Inventory-II (BDI). We identified an elevated PAC signal (theta-alpha–beta phase (5–25 Hz)/gamma frequency (80–100 Hz) band) that is present in high BDI scores but not low BDI scores adult epilepsy patients in brain regions implicated in primary depression, including anterior cingulate cortex, amygdala and orbitofrontal cortex. Our results showed the application of PAC as a network-specific, electrophysiologic biomarker candidate for comorbid depression and its potential as treatment target for neuromodulation. |
---|---|
ISSN: | 1525-5050 1525-5069 |
DOI: | 10.1016/j.yebeh.2024.109659 |